Crispr Therapeutics shares owned by Vanguard Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Vanguard Asset Management
from 13F filings
Historical chart of Vanguard Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Vanguard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $3.7M | 77k | 47.57 |